Tag: FNC SVY

Total Investment of Approx. USD 7.3 Million in Malaria and TB R&D Projects With Partners Including European Vaccine Initiative, University of Copenhagen, and University...

TOKYO, July 17, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1 billion (USD 7.3...

Rad AI Named to CNBC Disruptor 50 List For Pioneering Generative AI in Healthcare

Recognition comes amid rapid growth, with Rad AI recently securing $68 million in Series C Funding and ranking 19th on the Deloitte Fast 500. SAN...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsFNC SVY

Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Gala Night of the 28th Shanghai International Film Festival Held in Shanghai

Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million

Tag: FNC SVY

Total Investment of Approx. USD 7.3 Million in Malaria and TB R&D Projects With Partners Including European Vaccine Initiative, University of Copenhagen, and University...

Rad AI Named to CNBC Disruptor 50 List For Pioneering Generative AI in Healthcare

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us